Peptide/Large Molecule Interaction Studies

Peptide/Large Molecule Interaction Studies

KD measurement of peptide binding to target protein: kinetics, affinity. In the below case, more than 500 peptides were tested and the KD of which range from mM to nM. Positive Peptide Peptide A Peptide B
Peptide/Large Molecule Interaction Studies

Biomolecular Interaction Analysis

Kinetics | Affinity | Thermodynamics How fast, strong & why… Is the binding of a lead antibody or compound? Specificity How specific & selective… Is this drug binding to its receptor? Concentration How much… Is the biologically active component in...
Peptide/Large Molecule Interaction Studies

Pharmacology, PK/PD, and Exploratory Toxicity

Mouse, rat, monkey SC, IP, IV bolus, IV infusion Bio-analytical development PK/PD modeling and simulation In vitro stability in biological matrices Single dose, repeated dose, dose range finding in rats and monkeys Efficacy studies 160+ cell line xenografts and 270+...
Peptide/Large Molecule Interaction Studies

ADC Release and Stability Testing

Our capabilities include the following assays: Antigen binding activity determination: ELISA, FACS Drug to Antibody ratio (DAR) determination: UV-Vis, LC-MS, HPLC-HIC, iCIEF, etc. Residues of free drug determination: LC-MS/MS In vitro efficacy and bioactivity...
Peptide/Large Molecule Interaction Studies

Case Study on T-DM1 (Kadcyla)

Trastuzumab-DM1 (T-DM1; biosimilar of Kadcyla®) was synthesized and was tested in an in vitro efficacy assay employing an in vivo xenograft model. The following results demonstrate the in-house T-DM1 has comparable tumor inhibition activity and in vivo PK profiles...
Peptide/Large Molecule Interaction Studies

Affinity Maturation

Apart from antibody humanization and antibody discovery from phage display, ChemPartner’s antibody engineering department also offers sequence optimization and affinity maturation services. We provide customized affinity maturation strategies [random mutagenesis...
Peptide/Large Molecule Interaction Studies

Fully Human Therapeutic mAb Discovery

ChemPartner’s proprietary fully human naïve phage library with diversity ~10^11. Efficient library selection and screening with high-throughput robotics. All V-genes were amplified with high fidelity from diverse healthy donors. Stringent cloning procedures ensure a...